Prosthesis, Mitral Valve, Percutaneously Delivered
The percutaneously delivered mitral valve prosthesis is a cardiovascular implant intended to replace a patient's diseased mitral heart valve using a catheter-based percutaneous approach, avoiding open-chest surgery. It is classified as FDA Class 3, the highest risk category, requiring Premarket Approval (PMA). Product code NPU carries both implant and life-sustaining flags and is reviewed by the Cardiovascular panel.
Research product code NPU in seconds
The Research Assistant summarizes clearances, adverse event trends and regulation context for a product code — and cites every record.
Free to try · every answer cites its records
Basic Information
- Product Code
- NPU
- Device Class
- FDA class 3
- Medical Specialty
- Unknown
- Review Panel
- CV
- Submission Type
- 2
Device Characteristics
Definition
These devices are intended to replace a patient's mitral heart valve. They are different from the classified device (heart valves) in that they are placed percutaniously and do not require open chest surgery or a cardiotomy for placement.
FEI Numbers
This FDA classification entry is associated with 15 FEI numbers. Click on an entry to view related FDA registrations.
Registration Numbers
This FDA classification entry is associated with 15 registration numbers. Click on an entry to view related FDA registrations.